首页> 外国专利> USE OF RECIPIENT ENDOTHELIAL CELLS FOR ENHANCED VASCULARIZATION OF TISSUE AND TISSUE-ENGINEERED CONSTRUCT TRANSPLANTS

USE OF RECIPIENT ENDOTHELIAL CELLS FOR ENHANCED VASCULARIZATION OF TISSUE AND TISSUE-ENGINEERED CONSTRUCT TRANSPLANTS

机译:受体内皮细胞在组织和组织工程化组织的增强血管化中的应用

摘要

The success of tissue transplantation, when immunological conflict is minimized, depends on the vascularization process. This process is very complex and requires time. During this time, transplanted tissue often has difficulty obtaining oxygen and nutrients. These factors have a profound influence on the survival of the transplanted tissue, especially if the tissue has poor angiogenic properties. For new vessel formation, endothelial cells from existing recipient microvessels must proliferate and migrate through the extracellular matrix into the transplanted tissue. However, if transplanted tissue is mixed with recipient endothelial cells or co-administered, vascularization and acceptance of auto-, allo-, and heterotransplants is enhanced. In addition, recipient endothelial cells can be used to enhance vascularization of three-dimensional tissue-engineered constructs.
机译:当免疫冲突最小化时,组织移植的成功取决于血管形成过程。这个过程非常复杂,需要时间。在这段时间内,移植的组织通常难以获得氧气和营养。这些因素对移植组织的存活有深远的影响,特别是如果组织的血管生成特性较差时。为了形成新的血管,来自现有受体微血管的内皮细胞必须增殖并通过细胞外基质迁移到移植组织中。但是,如果将移植的组织与受体内皮细胞混合或共同施用,则会增强自体,同种异体和异种移植的血管形成和接受度。另外,受体内皮细胞可用于增强三维组织工程构建体的血管形成。

著录项

  • 公开/公告号WO03020955A3

    专利类型

  • 公开/公告日2003-05-01

    原文格式PDF

  • 申请/专利权人 PACGEN CELLCO LLC;

    申请/专利号WO2002US27761

  • 发明设计人 REVAZOVA ELENA;SEBASTIAN JEFF;

    申请日2002-08-30

  • 分类号A01N63/00;

  • 国家 WO

  • 入库时间 2022-08-21 23:54:06

获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号